{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:30:43Z","timestamp":1769581843459,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Bristol-Myers Squibb"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00296-018-4152-8","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T03:01:22Z","timestamp":1537758082000},"page":"2289-2296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-2085","authenticated-orcid":false,"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-7146","authenticated-orcid":false,"given":"Teresa","family":"Ot\u00f3n-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4401-2551","authenticated-orcid":false,"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Calvo-Al\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-8064","authenticated-orcid":false,"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Rodr\u00edguez Heredia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Romero Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Luj\u00e1n Vald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Royo Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Baquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"6","key":"4152_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.berh.2010.10.001","volume":"24","author":"L Carmona","year":"2010","unstructured":"Carmona L, Cross M, Williams B, Lassere M et al (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24(6):733\u2013745. \n                    https:\/\/doi.org\/10.1016\/j.berh.2010.10.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"10086","key":"4152_CR2","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389(10086):2338\u20132348. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31491-5","journal-title":"Lancet"},{"issue":"6","key":"4152_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4152_CR4","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar2561","volume":"10","author":"I Gonzalez-Alvaro","year":"2008","unstructured":"Gonzalez-Alvaro I, Descalzo MA, Carmona L, Estudio de la Morbilidad y Expresion Clinica de la Artritis Reumatoide Study G (2008) Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort. Arthritis Res Ther 10(6):R138. \n                    https:\/\/doi.org\/10.1186\/ar2561","journal-title":"Arthritis Res Ther"},{"key":"4152_CR5","first-page":"382388","volume":"36","author":"E Toledano","year":"2017","unstructured":"Toledano E, Ortiz AM, Ivorra-Cortes J, Montes N et al (2017) Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. Clin Exp Rheumatol 36:382\u2013388","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"4152_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.reuma.2010.11.006","volume":"7","author":"M Robustillo Villarino","year":"2011","unstructured":"Robustillo Villarino M, Rodriguez Moreno J (2011) [Are useful prognostic factors in rheumatoid arthritis?]. Reumatol Clin 7(5):339\u2013342. \n                    https:\/\/doi.org\/10.1016\/j.reuma.2010.11.006","journal-title":"Reumatol Clin"},{"issue":"9","key":"4152_CR7","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1002\/art.22868","volume":"56","author":"M Bukhari","year":"2007","unstructured":"Bukhari M, Thomson W, Naseem H, Bunn D et al (2007) The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 56(9):2929\u20132935. \n                    https:\/\/doi.org\/10.1002\/art.22868","journal-title":"Arthritis Rheum"},{"issue":"8","key":"4152_CR8","first-page":"1691","volume":"30","author":"LM Jansen","year":"2003","unstructured":"Jansen LM, van Schaardenburg D, van der Horst-Bruinsma I, van der Stadt RJ et al (2003) The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 30(8):1691\u20131695","journal-title":"J Rheumatol"},{"issue":"4","key":"4152_CR9","first-page":"157","volume":"4","author":"KG Shojania","year":"2001","unstructured":"Shojania KG, Bero LA (2001) Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy. Eff Clin Pract 4(4):157\u2013162","journal-title":"Eff Clin Pract"},{"issue":"1","key":"4152_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13075-017-1266-4","volume":"19","author":"K Albrecht","year":"2017","unstructured":"Albrecht K, Zink A (2017) Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies. Arthritis Res Ther 19(1):68. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1266-4","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4152_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2009.120899","volume":"70","author":"H Kallberg","year":"2011","unstructured":"Kallberg H, Ding B, Padyukov L, Bengtsson C et al (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70(3):508\u2013511. \n                    https:\/\/doi.org\/10.1136\/ard.2009.120899","journal-title":"Ann Rheum Dis"},{"key":"4152_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211695","author":"MK Jonsson","year":"2017","unstructured":"Jonsson MK, Sundlisaeter NP, Nordal HH, Hammer HB et al (2017) Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Ann Rheum Dis. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2017-211695","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4152_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/00325481.2017.1319729","volume":"129","author":"SC Bae","year":"2017","unstructured":"Bae SC, Lee YH (2017) Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis. Postgrad Med 129(5):531\u2013537. \n                    https:\/\/doi.org\/10.1080\/00325481.2017.1319729","journal-title":"Postgrad Med"},{"issue":"8","key":"4152_CR14","doi-asserted-by":"publisher","first-page":"e2859","DOI":"10.1097\/MD.0000000000002859","volume":"95","author":"J Feng","year":"2016","unstructured":"Feng J, Chen Q, Yu F, Wang Z et al (2016) Body mass index and risk of rheumatoid arthritis: a meta-analysis of observational studies. Medicine (Baltimore) 95(8):e2859. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000002859","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4152_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/rheumatology\/kep169","volume":"48","author":"C Book","year":"2009","unstructured":"Book C, Algulin J, Nilsson JA, Saxne T et al (2009) Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis. Rheumatology 48(9):1088\u20131091. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep169","journal-title":"Rheumatology"},{"issue":"1","key":"4152_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acr.20553","volume":"64","author":"V Bejarano","year":"2012","unstructured":"Bejarano V, Hensor E, Green M, Haugeberg G et al (2012) Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(1):66\u201370. \n                    https:\/\/doi.org\/10.1002\/acr.20553","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"4152_CR17","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avina-Zubieta","year":"2008","unstructured":"Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M et al (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690\u20131697. \n                    https:\/\/doi.org\/10.1002\/art.24092","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4152_CR18","doi-asserted-by":"publisher","first-page":"e0146991","DOI":"10.1371\/journal.pone.0146991","volume":"11","author":"G Crepaldi","year":"2016","unstructured":"Crepaldi G, Scire CA, Carrara G, Sakellariou G et al (2016) Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis. PLoS One 11(1):e0146991. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0146991","journal-title":"PLoS One"},{"issue":"8","key":"4152_CR19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/acr.20188","volume":"62","author":"W Katchamart","year":"2010","unstructured":"Katchamart W, Johnson S, Lin HJ, Phumethum V et al (2010) Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken) 62(8):1128\u20131143. \n                    https:\/\/doi.org\/10.1002\/acr.20188","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"4152_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/RHU.0000000000000247","volume":"21","author":"P Santos-Moreno","year":"2015","unstructured":"Santos-Moreno P, Galarza-Maldonado C, Caballero-Uribe CV, Cardiel MH et al (2015) REAL-PANLAR project for the implementation and accreditation of centers of excellence in rheumatoid arthritis throughout Latin America: a consensus position paper from REAL-PANLAR group on improvement of rheumatoid arthritis care in latin America establishing centers of excellence. J Clin Rheumatol 21(4):175\u2013180. \n                    https:\/\/doi.org\/10.1097\/RHU.0000000000000247","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"4152_CR21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/rheumatology\/ken323","volume":"47","author":"LH Tuyl van","year":"2008","unstructured":"van Tuyl LH, Plass AM, Lems WF, Voskuyl AE et al (2008) Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology 47(10):1571\u20131576. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/ken323","journal-title":"Rheumatology"},{"issue":"2","key":"4152_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/acr.22108","volume":"66","author":"K Tymms","year":"2014","unstructured":"Tymms K, Zochling J, Scott J, Bird P et al (2014) Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care Res (Hoboken) 66(2):190\u2013196. \n                    https:\/\/doi.org\/10.1002\/acr.22108","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4152-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4152-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T04:23:55Z","timestamp":1589948635000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4152-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4152"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4152-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The authors declare no conflicts of interest with the scope of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}